BR112018072528A2 - método para produzir derivados de 1-fenil-1,2,4-triazol substituídos por 5-hidroxialquila - Google Patents

método para produzir derivados de 1-fenil-1,2,4-triazol substituídos por 5-hidroxialquila

Info

Publication number
BR112018072528A2
BR112018072528A2 BR112018072528-5A BR112018072528A BR112018072528A2 BR 112018072528 A2 BR112018072528 A2 BR 112018072528A2 BR 112018072528 A BR112018072528 A BR 112018072528A BR 112018072528 A2 BR112018072528 A2 BR 112018072528A2
Authority
BR
Brazil
Prior art keywords
phenyl
triazole derivatives
producing
hydroxyalkyl substituted
triazol
Prior art date
Application number
BR112018072528-5A
Other languages
English (en)
Portuguese (pt)
Inventor
Schirmer Heiko
Rubenbauer Philipp
Militzer Hans-Christian
Collin-Kröpelin Marie-Pierre
Süssmeier Frank
Matthias Gericke Kersten
Neubauer Thomas
Fürstner Chantal
Original Assignee
Bayer Pharma Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Pharma Aktiengesellschaft filed Critical Bayer Pharma Aktiengesellschaft
Publication of BR112018072528A2 publication Critical patent/BR112018072528A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41961,2,4-Triazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/101,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12Oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
BR112018072528-5A 2016-05-03 2017-05-02 método para produzir derivados de 1-fenil-1,2,4-triazol substituídos por 5-hidroxialquila BR112018072528A2 (pt)

Applications Claiming Priority (13)

Application Number Priority Date Filing Date Title
EP16168165 2016-05-03
EP16168169.7 2016-05-03
EP16168166.3 2016-05-03
EP16168163.0 2016-05-03
EP16168163 2016-05-03
EP16168172.1 2016-05-03
EP16168172 2016-05-03
EP16168166 2016-05-03
EP16168169 2016-05-03
EP16168165.5 2016-05-03
EP17160086 2017-03-09
EP17160086.9 2017-03-09
PCT/EP2017/060367 WO2017191104A1 (de) 2016-05-03 2017-05-02 Verfahren zur herstellung von 5-hydroxyalkyl-substituierten 1-phenyl-1,2,4-triazolderivativen

Publications (1)

Publication Number Publication Date
BR112018072528A2 true BR112018072528A2 (pt) 2019-03-26

Family

ID=58633014

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018072528-5A BR112018072528A2 (pt) 2016-05-03 2017-05-02 método para produzir derivados de 1-fenil-1,2,4-triazol substituídos por 5-hidroxialquila

Country Status (19)

Country Link
US (2) US10703742B2 (https=)
EP (1) EP3452467A1 (https=)
JP (2) JP6921863B2 (https=)
KR (1) KR20190003536A (https=)
CN (2) CN109071500B (https=)
AU (2) AU2017259872B2 (https=)
BR (1) BR112018072528A2 (https=)
CA (1) CA3022789A1 (https=)
CL (1) CL2018003107A1 (https=)
CO (1) CO2018011948A2 (https=)
IL (1) IL262534B (https=)
JO (1) JOP20170103A1 (https=)
MX (2) MX391356B (https=)
PE (1) PE20190202A1 (https=)
RU (1) RU2742885C2 (https=)
SG (1) SG11201809672YA (https=)
TW (1) TWI755393B (https=)
UY (1) UY37222A (https=)
WO (1) WO2017191104A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JOP20170103A1 (ar) * 2016-05-03 2017-11-03 Bayer Pharma AG عملية لتحضير مشتقات 1-فنيل-1، 2، 4-تريازول مستبدلة بـ 5-هيدروكسي ألكيل
US9988367B2 (en) * 2016-05-03 2018-06-05 Bayer Pharma Aktiengesellschaft Amide-substituted pyridinyltriazole derivatives and uses thereof
JP6911052B2 (ja) * 2016-05-03 2021-07-28 バイエル ファーマ アクチエンゲゼルシャフト オキソアルキル置換フェニルトリアゾール誘導体およびその使用
WO2021259852A1 (en) 2020-06-25 2021-12-30 Bayer Aktiengesellschaft Process for preparing 5-(alkoxycarbonyl)-and 5-(carboxamide)-1-aryl-1,2,4-triazole derivatives
CN118894815A (zh) * 2024-07-12 2024-11-05 西北师范大学 一种含三氟甲基的1,2,4-三氮唑啉类衍生物及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8183384B2 (en) * 2006-05-25 2012-05-22 Synta Pharmaceuticals Corp. Triazole compounds that modulate HSP90 activity
US20110237528A1 (en) * 2008-09-19 2011-09-29 Institute For Oneworld Health Compositions and methods comprising imidazole and triazole derivatives
DE102010001064A1 (de) 2009-03-18 2010-09-23 Bayer Schering Pharma Aktiengesellschaft Substituierte 2-Acetamido-5-Aryl-1,2,4-triazolone und deren Verwendung
EA023221B1 (ru) * 2010-02-27 2016-05-31 Байер Интеллектуэль Проперти Гмбх СВЯЗАННЫЕ БИС-АРИЛЬНЫЕ АРИЛ-ТРИАЗОЛОНЫ, СПОСОБЫ ИХ ПОЛУЧЕНИЯ, ИХ ПРИМЕНЕНИЕ, ЛЕКАРСТВЕННОЕ СРЕДСТВО НА ИХ ОСНОВЕ И ДВОЙНОЙ АНТАГОНИСТ V1a/V2-РЕЦЕПТОРОВ
AU2013258107B2 (en) * 2012-05-08 2017-06-22 Bayer Pharma Aktiengesellschaft Method for the preparation of triazole compounds
UA121558C2 (uk) * 2014-11-03 2020-06-25 Баєр Фарма Актіенгезеллшафт Гідроксіалкілзаміщені фенілтриазольні похідні та їх застосування
JOP20170103A1 (ar) * 2016-05-03 2017-11-03 Bayer Pharma AG عملية لتحضير مشتقات 1-فنيل-1، 2، 4-تريازول مستبدلة بـ 5-هيدروكسي ألكيل
US9988367B2 (en) * 2016-05-03 2018-06-05 Bayer Pharma Aktiengesellschaft Amide-substituted pyridinyltriazole derivatives and uses thereof
JP6911052B2 (ja) * 2016-05-03 2021-07-28 バイエル ファーマ アクチエンゲゼルシャフト オキソアルキル置換フェニルトリアゾール誘導体およびその使用

Also Published As

Publication number Publication date
RU2742885C2 (ru) 2021-02-11
MX379555B (es) 2025-03-11
UY37222A (es) 2017-11-30
JP6921863B2 (ja) 2021-08-18
AU2017259872A1 (en) 2018-11-22
JP2021143193A (ja) 2021-09-24
RU2018142264A3 (https=) 2020-08-19
US20200299271A1 (en) 2020-09-24
AU2017259872B2 (en) 2021-06-24
JP2019514948A (ja) 2019-06-06
SG11201809672YA (en) 2018-11-29
MX2018013336A (es) 2019-05-09
PE20190202A1 (es) 2019-02-05
AU2021236502A1 (en) 2021-10-21
KR20190003536A (ko) 2019-01-09
CL2018003107A1 (es) 2019-02-22
CN113105403A (zh) 2021-07-13
CO2018011948A2 (es) 2018-11-22
MX2020010365A (es) 2022-04-06
WO2017191104A1 (de) 2017-11-09
JOP20170103A1 (ar) 2017-11-03
US20190144431A1 (en) 2019-05-16
RU2018142264A (ru) 2020-06-03
CA3022789A1 (en) 2017-11-09
TW201815782A (zh) 2018-05-01
MX391356B (es) 2025-03-19
US10703742B2 (en) 2020-07-07
IL262534B (en) 2021-04-29
TWI755393B (zh) 2022-02-21
EP3452467A1 (de) 2019-03-13
CN109071500A (zh) 2018-12-21
IL262534A (en) 2018-12-31
CN109071500B (zh) 2021-05-18

Similar Documents

Publication Publication Date Title
BR112018072528A2 (pt) método para produzir derivados de 1-fenil-1,2,4-triazol substituídos por 5-hidroxialquila
IL281196A (en) Process for the preparation of methyl 6-(4,2-dichlorophenyl)-5-[4-[(S3)-1-(3-fluoropropyl)pyrrolidin-3-yl]oxyphenyl]-9,8-dihydro-H7-benzo[ 7]Anolene-2-carboxylate
CL2014000384A1 (es) Compuestos fungicidas de 1-(2-(2-halo-4-(4-halogen-fenoxi)-fenil)-2-alcoxi-2-alquinil/alquenil-etil)-1h-(1,2,4) triazol sustituidos; proceso para preparar dichos compuestos; composiciones agroquímicas.
WO2013042138A3 (en) Process for preparation of triazole antifungal drug, its intermediates and polymorphs thereof
EA023517B1 (ru) Модуляторы глюкагонового рецептора
JP5647268B2 (ja) 新規抗真菌性トリアゾール誘導体
CL2014000202A1 (es) Compuestos fungicidas de 1-(2-(2-halo-4-(4-halogen-fenoxi)-fenil)-2-alcoxi-3-metil-butil)-1h(1,2,4)triazol sustituidos; proceso para preparar dicho compuesto; uso de dichos compuestos para combatir hongos fitopatogenos.
CL2014000201A1 (es) Compuestos fungicidas de 1-(2-(2-halo-4-(4-halogen-fenoxi)-fenil)-2-aluiniloxi-etil)-1h-(1,2,4)triazol sustituidos; procesos para preparar dichos compuestos; uso de dichos compuestos para combatir hongos fitopatógenos.
AR103843A1 (es) Combinaciones de compuestos activos
RU2013104939A (ru) Амиды антралиновой кислоты в комбинации с фунгицидами
ME01462B (me) Vinilindazolilna jedinjenja"
JP2014070075A5 (https=)
FI3848027T3 (fi) Oktahydrofuusioituja atsadekaliiniglukokortikoidireseptorin modulaattoreita
JP2017512803A5 (https=)
JP2011530593A5 (https=)
IL285675A (en) Crystalline form of 1-(1-oxo-2,1-dihydroisoquinolin-5-yl)-5-(trifluoromethyl)-n-(2-(trifluoromethyl)pyridin-4-yl)-1h-pyrazole-4-carboxamide monohydrate
AU2017375012A1 (en) Phenylamidines and the use thereof as fungicides
CA2331187C (en) Water soluble azoles as broad-spectrum antifungals
CL2014003003A1 (es) Proceso para la preparacion de 1-[6-(morfolin—4-il)pirimidin-4-il]-4-(1h-1,2,3-triazol-1-il)-1h-pirazol-5-ol (i – forma enol) o de 2-[6-(morfolin-4-il)pirimidin-4-il]-4-(1h-1,2,3-triazol-1-il)-1,2-dihidro-3h-pirazol-3-ona (i – forma ceto); y compuesto intermediario (2e/z)-3-(dimetilamino)-2-(1h-1,2,3-triazol-1-il) acrilato de metilo.
WO2010055896A3 (en) Pyridine derivative or its salt, pesticide containing it and process for its production
MY198496A (en) Method for producing 5-hydroxyalkyl-substituted 1-phenyl-1,2,4- triazole derivatives
DOP2020000076A (es) Profármacos de derivados de triazol sustituido y sus usos
RU2203280C2 (ru) Производные триазола, обладающие противогрибковой активностью
EP3233079A4 (en) (s)-n-(3-(6-isopropoxypyridin-3-yl)-1h-indazol-5-yl)-1-(2-(4-(4-(1-methyl-1h-1,2,4-triazol-3-yl)phenyl)-3,6-dihydropyridin-1(2h)-yl)-2-oxoethyl)-3-(methylthio)pyrrolidine-3-carboxamide compositions for pharmaceutical preparations
PT2089030E (pt) Agente para profilaxia ou tratamento da dependência do álcool e da dependência de substâncias

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B11D Dismissal acc. art. 38, par 2 of ipl - failure to pay fee after grant in time